Over the past 12 months, dozens of cannabis and cannabis-related bills were introduced to Congress. Some measures were renewed, others were introduced for the first time; however, each legislation dealt with a niche aspect of...more
1/21/2022
/ Agribusiness ,
Cannabidiol (CBD) oil ,
Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Corporate Counsel ,
Decriminalization of Marijuana ,
Dispensaries ,
Hemp ,
Hemp Related Businesses ,
Marijuana ,
Marijuana Cultivation ,
Marijuana Related Businesses ,
Medical Marijuana ,
New Legislation ,
Pending Legislation ,
Recreational Use ,
State and Local Government
The 117th Congress is shaping up to be the year for cannabis reform. As of April 2021, 47 states, four U.S. territories and the District of Columbia have legalized medical cannabis, recreational cannabis or both. Many of...more
4/22/2021
/ Agribusiness ,
Cannabidiol (CBD) oil ,
Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Decriminalization of Marijuana ,
Dispensaries ,
Marijuana ,
Marijuana Cultivation ,
Marijuana Related Businesses ,
Medical Marijuana ,
Recreational Use ,
State and Local Government
One of the most debated cannabis bills in the history of Congress is H.R.3884, the Marijuana Opportunity Reinvestment and Expungement (MORE) Act. Sponsored by House Judiciary Committee Chair Rep. Jerry Nadler (D-NY), the bill...more
While Tuesday’s General Election has left the watching public with questions about how political power dynamics will operate in D.C. next year, public sentiment nationwide has clearly coalesced around legalizing medical and...more
The past year has seen a veritable tidal wave of consumer product marketing claiming that cannabidiol (CBD) infused or derived products cure or treat cancer, epilepsy, anxiety, inflammation, diabetes, Alzheimer’s disease,...more
12/9/2019
/ Cannabidiol (CBD) oil ,
Cannabis Products ,
Comment Period ,
Dietary Supplements ,
Farm Bill ,
FDA Warning Letters ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Food and Drug Administration (FDA) ,
Health and Safety ,
Health Claims ,
Public Comment ,
Regulatory Requirements